Standardisation of Factor VIII – V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand Factor Activities in Plasma

Summary

The proposed 2nd International Standard for Factor VIII and von Willebrand Factor activities in plasma, NIBSC code 87/718, was assayed against the 1st IRP, 80/511, and against fresh normal plasma, in 21 laboratories. There were no significant differences between the various assay methods for factor VIII antigen, von Willebrand factor antigen, and von Willebrand factor ristocetin co-factor activity. For factor VIII clotting activity there was a significant difference between the results of one-stage and two-stage assays. Plasma 87/718 has now been established by the WHO Expert Committee on Biological Standardisation as the 2nd IS for factor VIII and vWF in plasma with the following potencies: VIII:C 0.60 IU/ampoule; VIII:Ag 0.91 IU/ampoule; vWF:Ag 0.91 IU/ampoule; vWF/RCo 0.84 IU/ampoule.

• References

• 1 WHO Technical Report Series 1983 687. 23-24
• 2 Barrowcliffe TW, Tydeman MA, Kirkwood TBL, Thomas DP. Standardization of Factor VIII. III: Establishment of a stable reference plasma for Factor VIII-related activities. Thromb Haemostas 1983; 50: 690-696
• 3 Finney D. Statistical Method in Biological Assay. Charles Griffin; London: 1978
• 4 Kirkwood TBL. Geometric means and measures of dispersion. Biometrics 1979; 35: 908-909
• 5 Kirkwood TBL. Predicting the stability of biological standards and products. Biometrics 1977; 33: 736-742
• 6 Krachmalnicoff A, Thomas DP. The stability of factor VIII in heparinised plasma. Thromb Haemostas 1983; 49: 224-227
• 7 Rodeghiero F, Castamans G. Calibration of lyophilised standards for ristocetin co-factor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curves. Thromb Haemostas 1987; 58: 978-981
• 8 WHO Technical Report Series 1989 786. 20-21